It is estimated more than 53,000 New Jerseyans will be diagnosed with cancer this year.
Step therapy practices can cause adverse reactions, debilitating side effects and unnecessary hospitalizations. For cancer patients and other New Jersey residents living with life-threatening conditions, these practices waste precious time and can lead to potentially deadly disease progression. And in instances when step therapy practices are unavoidable, it’s important that appropriate patient protections are in place.
ACS CAN will advocate for legislation that places limits on step therapy policies used by insurance companies that require patients to try less expensive, potentially less effective drugs before they can get coverage for the prescriptions their physicians recommend.